Grant E. Blouse - 12 Jul 2021 Form 3 Insider Report for CATALYST BIOSCIENCES, INC. (GYRE)

Signature
/s/ Faisal Shawwa Attorney-in-Fact for Grant E. Blouse
Issuer symbol
GYRE
Transactions as of
12 Jul 2021
Net transactions value
$0
Form type
3
Filing time
15 Jul 2021, 17:14:09 UTC
Next filing
11 Aug 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CBIO Common Stock 1,754 12 Jul 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CBIO Stock Option (Right to Buy) 12 Jul 2021 Common Stock 30,000 $12.21 Direct F2
holding CBIO Stock Option (Right to Buy) 12 Jul 2021 Common Stock 10,000 $9.68 Direct F3
holding CBIO Stock Option (Right to Buy) 12 Jul 2021 Common Stock 18,000 $7.97 Direct F4
holding CBIO Stock Option (Right to Buy) 12 Jul 2021 Common Stock 35,000 $6.85 Direct F5
holding CBIO Stock Option (Right to Buy) 12 Jul 2021 Common Stock 38,500 $5.89 Direct F6
holding CBIO Stock Option (Right to Buy) 12 Jul 2021 Common Stock 25,000 $4.33 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on various dates between February 11, 2019 and February 9, 2021.
F2 25% of the shares subject to the option vested on the one-year anniversary of the vesting commencement date of July 2, 2018, and 1/48 of the shares subject to the option vested or will vest on each monthly anniversary of the vesting commencement date thereafter.
F3 25% of the shares subject to the option vested on the one-year anniversary of the vesting commencement date of July 1, 2018, and 1/48 of the shares subject to the option vested or will vest on each monthly anniversary of the vesting commencement date thereafter.
F4 The option vested or will vest over a four (4) year period on each monthly anniversary of the vesting commencement date of January 24, 2019.
F5 The option vested or will vest over a four (4) year period on each monthly anniversary of the vesting commencement date of January 23, 2020.
F6 25% of the shares subject to the option will vest on the one-year anniversary of the vesting commencement date of February 8, 2021, and 1/48 of the shares subject to the option will vest on each monthly anniversary of the vesting commencement date thereafter.
F7 25% of the shares subject to the option will vest on the one-year anniversary of the vesting commencement date of June 16, 2021, and 1/48 of the shares subject to the option will vest on each monthly anniversary of the vesting commencement date thereafter.